Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended Treatments, Study Finds - Cancer Currents Blog

Having trouble viewing this email? View it as a Web page.
Cancer Currents 10 Year Banner with NCI White Banner on top

02/18/2025
Many U.S. doctors aren’t using the recommended initial treatments for their patients with hormone-sensitive metastatic prostate cancer, a new study has found. Often, it’s because they aren’t up to date on the latest treatment recommendations or because of side effect concerns.

Read the Story

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Bookmark and Share